Related Experiment Video
Updated: Nov 3, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Assessing Impact of Platinum Complexes on Mitochondrial Functions
1State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, P. R. China.
Abstract:
Platinum-based antitumor drugs play important roles in the clinical treatment of various tumors. Nevertheless, some deficiencies such as poor targeting ability, low bioavailability, in vivo deactivation, drug resistance, and side effects undermine the efficacy of these drugs. Mitochondria are important organelles which regulate the energy metabolism, physiological function, life span, and survival of the cells. Regulating or interfering with mitochondrial metabolism is of great significance in the prevention or treatment of cancers. Thus, a series of mitochondrion-targeted platinum complexes were prepared by modifying triphenylphosphine (TPP+) through chemical modifications, which endow traditional platinum drugs with new properties and mechanisms through interfering with mitochondrial DNA (mtDNA), mitochondrial membrane potential (MMP), mitochondrial morphology, mitochondrial bioenergetics, or production of reactive oxygen species (ROS), thereby opening a new path for the clinical application of platinum drugs. Here we introduce the synthesis of some TPP+-modified platinum (II, IV) complexes in details and the detection method of the activity parameters related to the mitochondrial functions.
Insights
New platinum-based anticancer drugs target mitochondria, overcoming limitations of traditional platinum drugs. These mitochondrion-targeted complexes offer a promising new strategy for cancer treatment by interfering with cellular energy and survival mechanisms.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Platinum-based drugs are crucial in cancer therapy but suffer from poor targeting, low bioavailability, and resistance.
- Mitochondria play vital roles in cell metabolism, survival, and cancer progression, making them a key target for cancer intervention.
Purpose of the Study:
- To develop novel platinum complexes with enhanced anti-cancer efficacy by targeting mitochondria.
- To explore new mechanisms of action for platinum-based drugs through mitochondrial interference.
Main Methods:
- Chemical modification of platinum complexes with triphenylphosphine (TPP+) to achieve mitochondrial targeting.
- Investigation of the effects of TPP+-modified platinum complexes on mitochondrial DNA (mtDNA), mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) production.
Main Results:
- Successful synthesis of TPP+-modified platinum (II, IV) complexes.
- Demonstration that these complexes can interfere with mitochondrial functions, including mtDNA, MMP, morphology, bioenergetics, and ROS production.
Conclusions:
- TPP+-modified platinum complexes represent a novel class of anticancer agents with improved targeting and efficacy.
- Targeting mitochondrial functions with platinum drugs opens new therapeutic avenues for cancer treatment.
More Related Videos
05:45Author Spotlight: Unveiling Oxidative Phosphorylation System Dynamics and Mitochondrial Roles in Health and Disease
Published on: May 3, 2024
08:03Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
The Supercomplexes in the Crista Membrane
Mitochondria
Electron Transport Chain: Complex III and IV
Mitochondrial Membranes